Editas Medicine (EDIT) Interest Expenses (2025)

Name: Editas Medicine (EDIT) Interest Expenses (2025) | Business Quant
Creator: Business Quant

Editas Medicine (EDIT) reported Interest Expenses of $2.4 million for Q3 2025, up 18.76% on a QoQ basis from $2.0 million in Q2 2025.

Editas Medicine (EDIT) has 1 years of Interest Expenses data on file, last reported at $2.4 million in Q3 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Quantum Biopharma	1,216,509.61 Bn	1,216,509.61 Bn	-	22,854.00
2	Alterity Therapeutics	764,224.41 Bn	764,224.38 Bn	-	-
3	Legend Biotech	2,716.00 Bn	2,715.71 Bn	242.10 Mn	-5.50 Mn
4	Nanobiotix	2,248.83 Bn	2,248.77 Bn	-	-
5	Akari Therapeutics	1,951.18 Bn	1,951.17 Bn	-	61,000.00
6	Vertex Pharmaceuticals	113.69 Bn	106.44 Bn	2.59 Bn	-
7	Evaxion A	64.16 Bn	64.14 Bn	-	-332,000.00
8	Regeneron Pharmaceuticals	63.94 Bn	55.18 Bn	3.31 Bn	12.90 Mn
9	Alnylam Pharmaceuticals	40.13 Bn	37.12 Bn	959.66 Mn	69.29 Mn
10	Editas Medicine	338.62 Mn	338.62 Mn	-	-

Download Data 🔒